These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23978012)

  • 1. [Relapse of acute leukemia after allogeneic stem cell transplantation: its mechanisms and strategies for the prevention and treatment].
    Wang JM
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):649-50. PubMed ID: 23978012
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention and treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation for acute leukemias].
    Da WM; Wu T; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2007 Dec; 28(12):793-4. PubMed ID: 18476587
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation].
    Liu C; Liu QF
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):729-32. PubMed ID: 23978031
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course.
    Lee KH; Lee JH; Choi SJ; Lee JH; Kim S; Seol M; Lee YS; Kim WK; Seo EJ; Park CJ; Chi HS; Lee JS
    Bone Marrow Transplant; 2003 Oct; 32(8):835-42. PubMed ID: 14520431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second allogeneic hematopoietic stem cell transplantation as treatment for leukemia relapsing following a first transplant.
    Blau IW; Basara N; Bischoff M; Günzelmann S; Römer E; Kirsten D; Schmetzer B; Kiehl MG; Fauser AA
    Bone Marrow Transplant; 2000 Jan; 25(1):41-5. PubMed ID: 10654013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Donor peripheral hematopoietic stem cells infusion for prophylaxis of relapse of high risk leukemia after allogeneic hematopoietic stem cell transplantation].
    Liu DH; Huang XJ; Chen H; Xu LP; Liu KY; Han W; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):6-9. PubMed ID: 16732930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimerism-directed adoptive immunotherapy in prevention and treatment of post-transplant relapse of leukemia in childhood.
    Formánková R; Sedlácek P; Krsková L; Ríhová H; Srámková L; Star J;
    Haematologica; 2003 Jan; 88(1):117-8. PubMed ID: 12551838
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of natural killer cells in hematopoietic stem cell transplantation.
    Tsirigotis PD; Resnick IB; Shapira MY
    Ann Med; 2012 Mar; 44(2):130-45. PubMed ID: 21410396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Induction of aGVHD after allogeneic hematopoietic stem cell transplantation for refractory or relapsed acute leukemia].
    Sun J; Meng FY; Liu QF; Xu D; Xu B; Liu XL
    Ai Zheng; 2003 Dec; 22(12):1321-4. PubMed ID: 14693060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of acute myeloid leukemia relapse after allogeneic stem cell transplantation.
    Oran B; de Lima M
    Curr Opin Hematol; 2011 Nov; 18(6):388-94. PubMed ID: 21897227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage high-dose chemotherapy with allogeneic stem-cell support for relapse or incomplete remission following high-dose chemotherapy with autologous stem-cell transplantation for hematologic malignancies.
    Tecnologica MAP Suppl; 2000 Jun; ():16-9. PubMed ID: 11067684
    [No Abstract]   [Full Text] [Related]  

  • 12. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantation.
    Cho BS; Lim JY; Yahng SA; Lee SE; Eom KS; Kim YJ; Chung NG; Jeong DC; Lee S; Kim HJ; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Min CK
    Ann Hematol; 2012 Mar; 91(3):439-48. PubMed ID: 21894475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia.
    Barrios M; Jiménez-Velasco A; Román-Gómez J; Madrigal ME; Castillejo JA; Torres A; Heiniger A
    Haematologica; 2003 Jul; 88(7):801-10. PubMed ID: 12857560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
    Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow or peripheral blood stem cell transplantation.
    Elmaagacli AH; Beelen DW; Trenschel R; Schaefer UW
    Bone Marrow Transplant; 2000 Jan; 25(1):91-6. PubMed ID: 10654021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change.
    Christopeit M; Kuss O; Finke J; Bacher U; Beelen DW; Bornhäuser M; Schwerdtfeger R; Bethge WA; Basara N; Gramatzki M; Tischer J; Kolb HJ; Uharek L; Meyer RG; Bunjes D; Scheid C; Martin H; Niederwieser D; Kröger N; Bertz H; Schrezenmeier H; Schmid C
    J Clin Oncol; 2013 Sep; 31(26):3259-71. PubMed ID: 23918951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Second allogeneic progenitor cell transplantation for leukemia relapse: results in 10 patients].
    Martínez C; Carreras E; Sierra J; Rovira M; Urbano-Ispizua A; Viguria MC; Vela D; Rozman C; Montserrat E
    Med Clin (Barc); 1997 Oct; 109(11):401-5. PubMed ID: 9379728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study of prophylactic ex vivo costimulated donor leukocyte infusion after reduced-intensity conditioned allogeneic stem cell transplantation.
    Kumar AJ; Hexner EO; Frey NV; Luger SM; Loren AW; Reshef R; Boyer J; Smith J; Stadtmauer EA; Levine BL; June CH; Porter DL; Goldstein SC
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1094-101. PubMed ID: 23635453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of intensified conditioning regimen for allogeneic hematopoietic stem cell transplantation for treatment of acute leukemias].
    Shigematsu A
    Rinsho Ketsueki; 2011 Aug; 52(8):667-73. PubMed ID: 21897073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.